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Highlights 
* Novel hyaluronate(HyA)-based biocompatible magnetic hydrogels were prepared. 
* Chondroitin-sulfate-A coating is needed to disperse magnetite particles in HyA-gel. 
* Rheological behaviour of hydrogels was independent of the magnetite content (<2 g/L). 
* Gels remained in stable and homogeneously dispersed state even after 90 days storage. 
* Magnetic HyA-gels are promising candidates for use as intra-articular injection. 
 
Abstract 
A novel soft way of hyaluronate (HyA) based magnetic hydrogel preparation was 
revealed. Magnetite nanoparticles (MNPs) were prepared by co-precipitation. Since the naked 
MNPs cannot be dispersed homogenously in HyA-gel, their surface was modified with natural 
and biocompatible chondroitin-sulfate-A (CSA) to obtain CSA-coated MNPs (CSA@MNPs). 
The aggregation state of MNPs and that loaded with increasing amount of CSA up to 1 mmol/g 
was measured by dynamic light scattering at pH~6. Only CSA@MNP with ≥0.2 mmol/g CSA 
content was suitable for magnetic HyA-gel preparation. Rheological studies showed that the 
presence of CSA@MNP with up to 2 g/L did not affect the hydrogel's rheological behaviour 
significantly. The results suggest that the HyA-based magnetic hydrogels may be promising 
formulations for future biomedical applications, e.g. as intra-articular injections in the treatment 
of osteoarthritis. 
 
Keywords: magnetite, chondroitin-sulfate-A, hyaluronate, magnetic hydrogels, surface 
modification, intra-articular injection 
 
 
1. Introduction 
Hydrogels are in the focus of scientific interest because of their tuneable mechanical, 
chemical and biocompatible properties [1,2]. These materials have been widely used in tissue 
engineering and drug delivery [1,3-5]. Magnetic hydrogels have also been produced by filling 
hydrogels with magnetic particles (e.g. maghemite, magnetite, cobalt-ferrite) [1], this procedure 
makes them more suitable for certain biomedical applications, such as drug delivery [1,6,7], 
enzyme immobilization [1,8-10] or cancer therapy by the combination of controlled drug 
release and magnetic hyperthermia [1,11]. Magnetic hydrogels have been prepared by three, 
fundamentally different methods: blending, in situ precipitation and grafting-onto methods [1]. 
Innumerable magnetic hydrogels have been synthesized, e.g. superparamagnetic magnetite 
nanoparticles (MNPs) in kappa-carrageenan nanospheres [12], in situ synthesized MNPs in 
chitosan hydrogel [13] and magnetic hydrogel of chitosan and MNPs for a potential cancer 
treatment [14]. Some hyaluronate (HyA) based magnetic hydrogels have been also prepared, 
e.g. hybrid magnetic hydrogels for controlled drug-delivery prepared from (3-
aminopropyl)trimethoxysilane-functionalized magnetite or cobalt-ferrite bound chemically to 
HyA by N-hydroxysuccinimide and N-(3-dimethylaminopropyl)-N-
ethylcarbodiimidehydrochloride [15]. Injectable in situ forming hydrogel has been synthesized 
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from oleic acid-coated iron oxide nanoparticles dispersed in toluene and hyaluronic acid 
modified with hydrazide and thiol groups (HA-hy-SH) for MRI contrast agent [16]. The giant 
HyA molecules flocculate MNPs and loose aggregates are formed, which can be prevented only 
by the pre-modification of either the MNP’s surface [15,17] or the chemical structure of HyA 
[18] or by the combination of the previous two [16,19]. Usually harmful chemicals were used 
during these preparations. In our laboratory, several types of core-shell magnetite nanoparticles 
have been produced [20-22] in the absence of risky chemicals by using poly(acrylic acid) (PAA) 
[23], poly(acrylic acid-co-maleic acid) (PAM) [24] and chondroitin-sulfate-A (CSA) [25] as 
coating agents to modify the MNP surface.  
The osteoarthritis (also called degenerative joint disease) is a common form of arthritis, 
which causes health problems for millions of people [26]. There are many reasons potentially 
responsible for the osteoarthritis, such as genetic factors, increased stress (i.e., hard physical 
work, sport, overweight) and decreased viscoelasticity of the intra-articular fluid. The latter can 
be caused by the reduced amount of hyaluronate (HyA) in the synovial fluid [27]. The 
supplement of synovial fluid by hyaluronate-containing intra-articular injection is a common 
treatment for osteoarthritis [26-30]. The typical composition of these gels (for example Hyalgan, 
Ostenil-Tendon, SportVis, Synvisc, Synocrom) is an isotonic solution (150 mM NaCl, pH ~7.3 
adjusted by buffer) containing 1% of sodium hyaluronate. There are several problems with this 
treatment, for example the rapid enzymatic degradation of HyA within the joints [31], the pain 
and the risk of infection during the injection procedure. Furthermore, during movement and 
under the weight of the patient’s body, the synovial fluid could be squeezed outside the joints 
reducing the efficiency of the intra-articular treatments. Our approach is to overcome the latter 
defect by using magnetic hydrogel and its flowability that can be regulated by an implanted 
permanent magnet. 
The aim of our research was to prepare HyA-based magnetic hydrogel samples in a soft 
way using biocompatible chemicals, which may be potentially used as an intra-articular 
injection in the future. The chemical structures of hyaluronate and biocompatible chondroitin-
sulfate-A are very similar (Fig. 1), so it is presumable that the surface of CSA-coated 
superparamagnetic magnetite nanoparticles (CSA@MNPs) is compatible with the HyA-gel. 
We intend to prepare stable MNPs and CSA-coated MNPs, and to test their stability and 
aggregation in dilute HyA-gels. Finally, we plan to prepare HyA-based magnetic hydrogels and 
to test the effect of increasing CSA@MNP concentration on the rheological properties. 
 
2. Materials and methods 
2.1. Materials 
The magnetite was prepared by co-precipitation [32-36]. The FeCl2, FeCl3 and NaOH 
for magnetite synthesis were analytical grade reagents obtained from Molar, Hungary. The 
precipitate was purified carefully through washing and dialysis. It was stored at pH~3 and 4 °C 
as stable sol. The resulting iron-oxide was identified as magnetite, based on the characteristic 
black colour, strong magnetism and the X-ray diffraction pattern (JCPDS database [37]). The 
mean diameter of the MNPs, determined by Scherrer equation and transmission electron 
microscopy, was ~10 nm [21]. 
The chondroitin-sulfate-A (CSA) was purchased from Sigma-Aldrich as sodium-salt, and the 
sodium-salt of hyaluronic acid (HyA) was kindly provided by the Department of 
Pharmaceutical Technology (University of Szeged, Hungary). One repeating unit of CSA 
(M=503 Da) contains one –COOH and one –SO3H group (Fig. 1a) and that of HyA (M=379 
Da) contains one –COOH group (Fig. 1b). The strongly acidic sulfate groups (–SO3–) in CSA 
are fully deprotonated at a wide pH-range [38,39]. However, the –COOH groups in CSA and 
HyA have pH-dependent dissociation (pKβ-glucuronic acid ~2.9) [40] but, even so, these groups are 
fully deprotonated (-COO–) at pH ~6.3 applied in our experiments. The notations "CSA" and 
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"HyA" are used in this article for sodium-salt regardless of the actual degree of dissociation of 
the carboxylic groups. The amount of CSA and HyA is expressed through the mole of repeating 
units, which equals to the number of dissociable –COOH groups. 
The CSA-coated magnetite nanoparticles (CSA@MNPs) were prepared at pH=6.3±0.3 
and 10 mM NaCl, the MNP-content was 20 g/L, the CSA-loading was 0.2, 0.4 and 1.0 mmol -
COOH/g MNP and the adsorption time was one day. These amounts of CSA completely coat 
MNPs and provide the high colloidal stability of the CSA@MNP particles [25]. 
The HyA-gel was prepared by the dissolution of hyaluronic acid in ultra pure water 
under one day long continuous stirring. The HyA-content of the stock-gel was 11 mg/mL and 
the pH was ~5.8. Thereafter, the calculated amounts of the naked MNPs or CSA@MNPs at 0.4 
mmol/g CSA-loading were added to 9 mL of the previously prepared HyA-gel under vigorous 
magnetic stirring and the total volume was adjusted to 10 mL using 10 mM NaCl solutions 
(pH=6.3±0.3). Stirring was continued for five minutes. The final HyA-content of the hydrogels 
was 10 mg/mL similar to that in commercial HyA-based intra-articular injections (for example 
Synocrom). The magnetite-content of the magnetic hydrogels was 2.0 g/L for the naked MNPs 
and 0.0, 0.2 and 2.0 g/L for CSA@MNPs at pH ~6.0 and ~1 mM NaCl. The HyA-gels were 
stored in closed vials at 4 °C. 
NaCl, HCl and NaOH, analytical grade products of Molar (Hungary), were used to 
adjust the pH and salt concentration in all experiments. Ultra pure water from a Milli-Q RG 
water purification system (Millipore) was used. All measurements were performed at 25±0.1 
°C. 
 
a)  b)  
Fig. 1. The repeating units of (a) chondroitin-sulfate-A (CSA) and (b) hyaluronic acid (HyA) [41]. 
 
2.2. Particle Size Determination 
For characterization of the aggregation state of magnetic nanoparticles in diluted HyA-
systems, the Z average particle hydrodynamic diameter of bare magnetite and of CSA-coated 
nanoparticles was determined at 25±0.1 °C using dynamic light scattering (DLS) method, an 
apparatus Nano ZS (Malvern) with a 4 mW He−Ne laser source (λ=633 nm) operating in 
backscattering mode at an angle of 173°. The dispersions contained 100 mg/L of magnetite to 
get an optimal intensity of ~105 counts per second. Prior to the measurements, the samples were 
homogenized in an ultrasonic bath for 10 s, after which 2 min relaxation was allowed. For 
evaluation, second- or third-order cumulant fit of the autocorrelation functions was used, 
depending on the degree of polydispersity. The influence of the added HyA amounts (0.0–2.5 
mmol HyA/g magnetite) was determined at pH=6.3±0.3 and 10 mM NaCl in case of MNPs and 
CSA@MNPs. The CSA-loadings were 0.2, 0.4, and 1.0 mmol CSA/g magnetite [25]. 
 
2.3. Electrokinetic potential measurements 
Electrophoretic mobilities of the naked magnetite and CSA@MNP dispersions were 
measured at 25±0.1 °C in a Nano ZS (Malvern) apparatus using disposable zeta cells (DTS 
1060). The zeta-standard of Malvern (-55±5 mV) was used for calibration. The Smoluchowski 
equation was applied to convert electrophoretic mobilities to electrokinetic potential values. 
The accuracy of the measurements was ±5 mV. The samples were identical to those in the DLS 
experiments. 
–O3SO
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2.4. Rheological measurements 
The flow properties of the prepared blank HyA- and magnetic HyA-gels (Section 2.1.) 
were characterized systematically. The rheological measurements of three-days old samples 
were carried out with a Physica MCR101 rheometer (Anton Paar, Austria) and a plate-plate 
measuring device (diameter: 5 cm) at 25±0.1 °C.  
Flow curves of the different samples were determined. The shear rate was increased 
from 0.5 to 50 s-1 (upward curve), and then it was decreased from 50 to 0.5 s-1 (downward 
curve) in the CR mode. The shearing time in both segments was 60 s. The downward curves 
over the plastic flow range (above shear rate ~20 s-1) were evaluated according to the Bingham-
model given by Eq. (1):  
 τ = τB + ηpl · dγ/dt (1) 
where τ is the shear stress, τB is the Bingham yield value, ηpl the plastic viscosity and dγ/dt the 
shear rate [42,43]).  
The creep tests were performed to determine the viscoelastic behavior under static 
condition. A constant stress (0.1 and 5.0 Pa) was applied for 60 s and the resulting deformation 
was measured (creep), then stress was released and the deformation was measured again for 60 
s (recovery). 
The dynamic tests of viscoelasticity were also conducted in forced oscillation 
measurements in the range of stress from 0.1 to 10 Pa at 1 Hz and of frequency from 0.1 to 10 
Hz at 1 Pa. Both storage modulus (G’) and loss modulus (G”) were analyzed. 
 
 
3. Results and discussion 
3.1. Electrokinetic potential, particle size and aggregation 
The changes in the Z average particle diameter and the electrokinetic potential of the 
naked and CSA-coated magnetite nanoparticles are plotted as a function of HyA-addition in 
Fig. 2. Photos in Fig. 3 show the change in colloidal stability of MNP and CSA@MNP at 0.4 
mmol/g CSA-loading as a function of HyA-addition after standing for one day. 
 
a) b)  
Fig. 2. Effect of HyA-addition on the (a) Z average particle diameter and (b) electrokinetic potential of MNPs 
and CSA@MNPs (CSA-loadings: 0.2, 0.4 and 1.0 mmol/g) at pH~6.3 and 10 mM NaCl, at a solid/liquid ratio of 
100 mg/L. (Lines are drawn as guides for the eye. The amounts of CSA and HyA are expressed as molar 
amounts of repeating units given in mmol.) 
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Fig. 3. Effect of increasing HyA addition (up to 2.5 mmol/g, see the numbers on the vials) on the colloidal 
stability of the naked MNP and CSA@MNP (CSA-loading: 0.4 mmol/g) dispersions after standing for 24 hours 
at pH~6.3 and 10 mM NaCl, at a solid/liquid ratio of 100 mg/L. 
 
With increasing HyA-concentration, the aggregation state of the originally naked MNPs 
changes characteristically (see Fig. 3). At pH~6.3 and 10 mM NaCl, the naked magnetite is 
aggregated and settled [23,24]. Although the net surface charge of MNP is positive due to the 
presence of ≡Fe–OH2+ groups on the surface [23,24,32,33,37,44-46], the amount of the charge 
is not enough to stabilize the particles electrostatically. The electrokinetic potential of the naked 
magnetite is ~+25 mV, and this sample is aggregated (~1000 nm) (see Fig. 2). In case of trace 
(<0.5 mmol/g) or very large (>1.5 mmol/g) amounts of HyA, the particles settle after 24 hours. 
However, at intermediate HyA-concentrations (~0.5-1.5 mmol/g) the magnetite dispersions are 
stable (middle samples in Fig. 3). The electrokinetic potential of the positive naked MNPs 
declines with the increase in the amount of added HyA because the negatively charged HyA 
adsorbed on MNPs. The charge neutralization occurs at ~0.05 mmol/g HyA-addition, resulting 
in surface charge heterogeneity due to the patch-wise adsorption of HyA. This marks the 
isoelectric point (IEP) and the size of HyA@MNP aggregates reaches maximum (~2300 nm). 
Further addition of HyA caused charge reversal and reduced the electrokinetic potential to ~-
40 mV. The electrosteric stabilization, typical for polyelectrolytes, can be observed only in the 
range of ~0.5-1.5 mmol/g HyA. Stabilization is accompanied by a low hydrodynamic diameter 
(~250 nm). The aggregation observed at larger HyA-addition (>1.5 mmol/g) is caused by the 
flocculation effect of the high molecular weight HyA, so these particles do not seem to be 
suitable for preparation of magnetic HyA-gels. 
The colloidal state of the originally stable CSA@MNPs [25] does not change with 
increasing HyA concentration (Fig. 3). The hydrodynamic diameters (~150 nm) and the 
electrokinetic potentials (~-40 mV) are independent from the CSA-loadings and the HyA-
addition (Fig. 2). Thus, the CSA@MNP particles can be used to prepare magnetic HyA-gels.  
 
3.2. Rheological measurements of hydrogels 
The photos of the HyA-hydrogels prepared at 10 mg/mL HyA concentration are shown 
in Fig. 4. As it was expectable from the DLS measurements of the diluted gels (Section 3.1.), 
the naked MNPs can not be dispersed homogeneously in the HyA-gel; however, the 
CSA@MNP particles are compatible with the hydrogels forming well dispersed systems. The 
CSA@MNP-containing magnetic hydrogels remained stable and homogeneously dispersed 
even after three months of storage. 
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Fig. 4. HyA-gels with MNP and CSA@MNP at different magnetite contents (see on the vials) (HyA-content: 10 
mg/mL, CSA-loading: 0.4 mmol/g, pH~6.0, 1 mM NaCl). 
 
The flow curves of the HyA-hydrogels at various CSA@MNP-contents are shown in 
Fig. 5. There is no significant change in the flow character of gels with increasing CSA@MNP-
loading. The upward and downward curves are identical. Thixotropy is not detected under the 
conditions of measurements. The downward curves were evaluated according to the Bingham-
model (Fig. 5). The Bingham yield values (τB) and the plastic viscosities (ηpl) of all gels (Table 
1) coincide within the error of the measurements. This is in good agreement with the expected 
tendency based on the Einstein-equation [47], since the volume fraction of magnetite particles 
is extremly low in these hydrogels (Ф≤0.004). 
 
  
Fig. 5. Effect of CSA@MNP-content on flow curves of HyA-gels (HyA-content: 10 mg/mL, CSA-loading: 0.4 
mmol/g, pH~6.0, 1 mM NaCl, 25 °C). (The upward and downward curves are identical. The equations of fitted 
Bingham model are marked.) 
 
The viscoelastic properties of gels can be studied under static conditions by creep tests. 
The measured data of the HyA-gels at different CSA@MNP contents are shown in Fig. 6 at 
two yield stress values (0.1 and 5.0 Pa). Both the HyA-gel and the magnetic hydrogels show 
viscous properties at the applied stress values showing that the extent of deformation depends 
on the applied stress, but it is independent of the magnetite content.  
 
naked
MNP
CSA@MNP
2.0            0.0      0.2     2.0 
MNP
g/L
0
10
20
30
40
50
0 10 20 30 40 50
Shear rate (s-1)
Sh
e
ar
 s
tr
e
ss
 (
P
a)
0 g/L
0.2 g/L
2 g/L
 
 
This is a PDF file of an unedited manuscript that has been accepted for publication. Final edited form is 
published in J Magn Magn Mater, 2015, 380:175–180. http://dx.doi.org/10.1016/j.jmmm.2014.10.139 
  
Fig. 6. Creep and recovery test results for HyA-gels at different CSA@MNP-content (HyA-content: 10 mg/mL, 
CSA-loading: 0.4 mmol/g, pH~6.0, 1 mM NaCl, 25 °C). 
 
The forced oscillation measurements are suitable to study the viscoelastic properties of 
gels under dynamic conditions. The oscillation tests of the HyA-gels at different CSA@MNP-
contents (Fig. 7) show that all the measured parameters are independent from the CSA@MNP-
content within the error of the measurements. 
During the oscillation measurements at 1 Hz (Fig. 7a) the loss modulus (G”) curves of 
gels are above the storage modulus (G’) curves in the whole range of stress (0.1 to 100 Pa). 
Thus, under the condition of measurements the hydrogels show viscous properties. However, 
during frequency sweep measurements at 1 Pa (Fig. 7b), the viscous loss modulus (G”) and the 
elastic storage modulus (G’) of gels cross each other. This is characteristic for the viscoelastic 
nature of HyA, i.e., at lower frequencies (analogous to the static position of the body) the HyA-
gel behaves as a viscous solution ensuring to hold the skeleton, however, at higher frequencies 
(analogous to the motion of the joints) the hydrogel behaves elastically allowing an effective 
lubrication between the cartilages [48-50]. This property is fundamental and essential for the 
natural synovial fluid. The transition from viscous to elastic behaviour can be characterized by 
the so-called crossover point (Table 1), which is at ~1.3 Hz for our magnetic HyA-gels in case 
of 1 Pa shear stress. 
 
a)   b)  
Fig. 7. Forced oscillation tests of HyA-gels at different CSA@MNP-content as a function (a) of shear stress at 1 
Hz and (b) of frequency at 1 Pa. (HyA-content: 10 mg/mL, CSA-loading: 0.4 mmol/g, pH~6.0, 1 mM NaCl, 25 
°C). 
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Table 1. Summary of the hydrogel's characteristic rheological parameters at different CSA@MNP contents 
(HyA-content: 10 mg/mL, CSA-loading: 0.4 mmol/g, pH~6.0, 1 mM NaCl, 25 °C).  
CSA@MNP magnetite content 0.0 g/L 0.2 g/L 2.0 g/L 
Bingham yield stress (Pa) 28.0 27.1 30.5 
plastic viscosity (Pa·s) 0.42 0.42 0.46 
crossover point (Hz) 1 1.3 1.1 1.4 
1 intersection point between the viscous and the elastic behaviour in forced oscillation during the frequency 
sweep at 1 Pa. 
 
The characteristic rheological parameters of the magnetic HyA-gel loaded with 2 g/L 
CSA@MNP (indicated as HyA + magnetite‒COO‒) can be compared with those of other HyA-
based magnetic hydrogels as shown in Table 2. It can be seen that the values of the different 
parameters for the listed hydrogels vary significantly, probably because these measurements 
were made under different conditions, such as temperature, salt concentration, pH, fixed 
frequency or stress, etc. There were differences even in the rate of cross-linking. Our magnetic 
hydrogels are not yet cross-linked, however, the un-bound carboxylate groups of both CSA and 
Hyal (as seen in Fig.1) are prone to react with Ca2+ions forming a cross-linked structure with 
tuneable flow properties. The latter will be the subject of our future studies. 
 
Table 2. Characteristic rheological parameters of different HyA-hydrogels. 
Hydrogels 
magne-
tic 
cross-
linked 
at linear range 
of stress sweep 
at crossover 
point in 
frequency sweep 
from flow 
curve 
  
G'  
(Pa) 
G'' 
(Pa) 
f 
(Hz) 
G'=G" 
(Pa) 
τB  
(Pa) 
ηpl 
(Pa·s) 
HyA + magnetite‒COO‒ 1 yes no 11 13 1.4 15 30 0.4 
HyA +magnetite‒NH2 [15] 2  yes yes 350 25 - - - - 
HyA-SH + iron-oxide‒COOH [16] 3 yes yes 510 - - - - - 
HyA [50] no no - - 0.02 20 120 0.7 
HyA [50] no yes - - 0.11 20 90 0.7 
HyA ~ Synvisc [51] 4 no yes 100 20 - - - - 
1 magnetite: chondroitin-sulfate-A-coated 
2 magnetite: 3-aminopropyl)trimethoxysilane-functionalized 
3 HyA: modified with hydrazide and thiol groups, iron-oxide: oleic acid coated in toluene 
4 commercially available intra-articular injection 
 
 
4. Conclusions 
The aim of this work was to prepare novel biocompatible HyA-based magnetic 
hydrogels using CSA-coated superparamagnetic magnetite nanoparticles and to characterize 
their aggregation state and rheological properties as well. The solid experimental facts allow us 
to conclude that HyA-based magnetic hydrogels can be prepared from CSA@MNPs and they 
remained stable and homogeneously dispersed even after three months of storage. Rheological 
studies show, that at pH~6.0 and 1 mM NaCl the behaviour of magnetic hydrogels was 
appreciably independent from the magnetite content up to 2 g/L. Further studies are needed at 
pH ~7.3, 150 mM NaCl and 37 °C to approximate the composition of commercial HyA-based 
intra-articular injections and in vivo conditions. However, the prepared HyA-based magnetic 
hydrogels are promising candidates for magnetic intra-articular fluid in the treatment of 
osteoarthritis. By implanting a permanent magnet into the bone in close vicinity of the knee 
joint for example, the magnetic HyA-gel with increased CSA@MNP content probably can be 
held at the eroded area. Thus, it is predictable that the necessary distance between the cartilages 
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can be provided to reduce the pain during motion and even the requested lubrication can be 
ensured in the joint for a longer time. 
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